Companies: 10,795·Total market cap: $144.5T
Avinger, Inc.

Avinger, Inc.

AVGRNASDAQHealthcare
$0.47
$-0.12(-20.74%)
Market Cap$1515364
P/E Ratio
52W High$4.3689
52W Low$0.363

Avinger, Inc. (AVGR) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

avgr · pe ratio · data through Dec 31, 2023

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Avinger, Inc. (AVGR) measures how much investors pay for each dollar of the company's trailing earnings. AVGR's current PE ratio of N/A is calculated by dividing its stock price of $0.47 by its TTM earnings per share of -$23.31.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31

Forward P/E
N/A
FY2026 est. EPS $-0.74
Based on 1 analyst
EPS (TTM)
-$23.31
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Avinger, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2012 – 2023 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Instruments & Supplies · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Avinger, Inc.
Avinger, Inc.You
AVGR
$2MN/A-$23.31
ASLAN Pharmaceuticals Limited
ASLAN Pharmaceuticals Limited
ASLN
$777MN/A-$10.75
CareMax, Inc.
CareMax, Inc.
CMAX
$2MN/A-$183.30
G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd
GMVD
$2MN/A$0.00
HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc.
HTGMQ
$0MN/A-$24.28
NAYA Biosciences, Inc.
NAYA Biosciences, Inc.
NAYA
$1MN/A-$29.39
NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc.
NBSE
$1MN/A-$21.08

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 12 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2023-12-31Latest
FY2023
$-23.31
2022-12-31
FY2022
$-41.83
2021-12-31
FY2021
$-65.79
2020-12-31
FY2020
$-120.80
2019-12-31
FY2019
$-818.60
2018-12-31
FY2018
$-7736.66
2017-12-31
FY2017
$-175927.80
2016-12-31
FY2016
$-283474.75
2015-12-31
FY2015
$-450895.24
2014-12-31
FY2014
$-389804.88

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Avinger, Inc. (AVGR) measures how much investors pay for each dollar of the company's trailing earnings. AVGR's current PE ratio of N/A is calculated by dividing its stock price of $0.47 by its TTM earnings per share of -$23.31.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.47 ÷ -$23.31 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

AVGR pe ratio · 6 questions

AVGR's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.47 and TTM EPS of -$23.31. Data sourced from Financial Modeling Prep via AVGR's SEC 10-K and 10-Q filings.

AVGR PE ratioWhat is AVGR PE ratioCurrent PE ratio of AVGRAVGR PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Avinger, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09